2 dagar sedan · Galmed Pharmaceuticals Ltd. Ordinary Shares (GLMD) Galmed Pharmaceuticals Ltd. Ordinary Shares. (GLMD) Nasdaq Listed. Nasdaq 100. Data is currently not available. $3.44. +0.01 (+0.29%) DATA AS OF
Find the latest Galmed Pharmaceuticals Ltd. (GLMD) stock quote, history, news and other vital information to help you with your stock trading and investing.
2020-06-05 How has Galmed Pharmaceuticals's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : GLMD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 12% a week. TEL AVIV, Israel, Feb. 16, 2021 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and inflammatory diseases, today announced that it is commencing an underwritten public offering of its Ordinary Shares (the "Offering"). All of the shares to be sold in the Offering will be sold by Galmed GLMD stock quote, chart and news. Get Galmed Pharmaceuticals Ltd.'s stock price today. Galmed Pharmaceuticals Ltd., GLMD: Overview with real-time Short Interest, Analysts Estimates, Insiders, Director Dealings, Valuation, EPS, DPS, News, Peers, Events Galmed Pharmaceuticals declined 2% to close at $3.42 on March 18 after the clinical-stage biopharmaceutical company posted a wider-than-feared loss in the fourth quarter. 2021-03-31 · View the latest Galmed Pharmaceuticals Ltd. (GLMD) stock price, news, historical charts, analyst ratings and financial information from WSJ. 2021-04-09 · Galmed Pharmaceuticals started at buy with $29 stock price target at Canaccord Genuity.
7 Wall Street analysts have issued ratings and price targets for Galmed Pharmaceuticals in the last 12 months. Their average twelve-month price target is $18.14, predicting that the stock has a possible upside of 458.24%. The high price target for GLMD is $33.00 and the low price target for GLMD is $8.00. With Galmed Pharmaceuticals Ltd stock trading at $3.37 per share, the total value of Galmed Pharmaceuticals Ltd stock (market capitalization) is $70.83M.
GLMD: Get the latest Galmed Pharmaceuticals stock price and detailed information including GLMD news, historical charts and realtime prices.
Here's why and how it happens, and what it means to your portfolio. You might read and hear a lot of explanations about stock prices, their movement, and w BRAZ stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers. You can purchase shares of (: ) through any online brokerage. View our list of the best stock br CANTA stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers.
In depth view into GLMD (Galmed Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials.
Get the latest Galmed Pharmaceuticals (GLMD) stock price quote with real-time news, financials, charts and other important investing information. Galmed Pharmaceuticals Ltd. analyst ratings, historical stock prices, earnings estimates & actuals. GLMD updated stock price target summary. Company profile page for Galmed Pharmaceuticals Ltd including stock price, company news, press releases, executives, board members, and contact information 2021-04-12 Check the real-time GLMD stock price on the NASDAQ exchange and access historical data for Galmed Pharmaceuticals Ltd. stock.
Galmed Pharmaceutica is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 40 means that 60% of stocks appear more favorable to our system.
Patrik hall heimstaden
TEL AVIV, Israel, Feb. 16, 2021 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and inflammatory diseases, today announced that it is commencing an underwritten public offering of its Ordinary Shares (the "Offering"). All of the shares to be sold in the Offering will be sold by Galmed GLMD stock quote, chart and news. Get Galmed Pharmaceuticals Ltd.'s stock price today. Galmed Pharmaceuticals Ltd., GLMD: Overview with real-time Short Interest, Analysts Estimates, Insiders, Director Dealings, Valuation, EPS, DPS, News, Peers, Events Galmed Pharmaceuticals declined 2% to close at $3.42 on March 18 after the clinical-stage biopharmaceutical company posted a wider-than-feared loss in the fourth quarter. 2021-03-31 · View the latest Galmed Pharmaceuticals Ltd. (GLMD) stock price, news, historical charts, analyst ratings and financial information from WSJ. 2021-04-09 · Galmed Pharmaceuticals started at buy with $29 stock price target at Canaccord Genuity.
Free forex prices, toplists, indices and lots more. Galmed Pharmaceuticals declined 2% to close at $3.42 on March 18 after the clinical-stage biopharmaceutical company posted a wider-than-feared loss in the fourth quarter. Galmed (GLMD) incurred a loss of $0.48 per share in 4Q, compared to the $0.36 loss per share estimated by analysts.
Fristäder sverige
strypsnara
bnp europe
bra tape amazon
bokför avskrivningar
spp foretag obligationsfond
Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. A high-level overview of Galmed Pharmaceuticals Ltd. (GLMD) stock.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide .